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Murine cytomegalovirus (MCMV) is widely used to model human cytomegalovirus (HCMV) infection.
However, it is known that serially passaged laboratory strains of HCMV differ significantly from recently
isolated clinical strains of HCMV. It is therefore axiomatic that clinical models of HCMV using serially
passaged strains of MCMV may not be able to fully represent the complexities of the system they are
attempting to model and may not fully represent the complex biology of MCMV. To determine whether
genotypic and phenotypic differences also exist between laboratory strains of MCMV and wild derived strains
of MCMV, we sequenced the genomes of three low-passage strains of MCMV, plus the laboratory strain, K181.
We coupled this genetic characterization to their phenotypic characteristics. In contrast to what is seen with
HCMV (and rhesus CMV), there were no major genomic rearrangements in the MCMV genomes. In addition,
the genome size was remarkably conserved between MCMV strains with no major insertions or deletions.
There was, however, significant sequence variation between strains of MCMV, particularly at the genomic
termini. These more subtle genetic differences led to considerable differences in in vivo replication with some
strains of MCMV, such as WP15B, replicating preferentially in otherwise-MCMV-resistant C57BL/6 mice.
CBA mice were no more resistant to MCMV than C57BL/6 mice and for some MCMV strains appeared to
control infection less well than C57BL/6 mice. It is apparent that the previously described host resistance
patterns of inbred mice and MCMV are not consistently applicable for all MCMV strains.
Human cytomegalovirus (HCMV) is a ubiquitous betaher-
pesvirus that causes life-long asymptomatic infection in the
immunocompetent host. In the immunocompromised host,
however, it can cause severe disease and is the leading infec-
tious cause of congenital abnormalities in the western world. It
is also one of the leading causes of posttransplant complica-
tion. It is now apparent that serially passaged laboratory strains
of HCMV, such as AD169, exhibit significant biological vari-
ation compared to low-passage clinical isolates of HCMV (25).
Recently, the complete genome of several different clinical
strains of HCMV has been sequenced (10, 24). Levels of amino
acid sequence similarity between the same gene from the dif-
ferent isolates range from 25 to 100%. More importantly per-
haps, the gene content between clinical isolates varies (23), and
it is apparent that serially passaged laboratory strains of
HCMV have lost a significant number of genes (8).
The in vivo consequences of these genetic variations cannot
be assessed due to the strict species specificities of cytomega-
loviruses (CMVs). It is because of this specificity that in vivo
studies of CMVs are typically modeled using CMVs from ei-
ther rat, mouse, or guinea pig; the most commonly used is the
mouse model with murine CMV (MCMV). MCMV shares
many features with HCMV. The genomes of both viruses are
colinear, and both viruses establish latent infection that reac-
tivates upon immunosuppression to cause disseminated, often
fatal, disease. Major cell types and organs infected by both
viruses, the course of infection, and the type of pathology seen,
are essentially identical, with the notable exception that
MCMV does not cross the placenta (29).
The vast bulk of research on MCMV uses one of two serially
passaged laboratory strain of MCMV: Smith or K181. The
Smith strain of MCMV was isolated by Margaret Smith in 1954
from the salivary gland tissue of infected laboratory mice (33).
The K181 strain of MCMV was later described as a more
virulent Smith strain variant and was isolated by June Osborn
from the salivary glands of mice after serial passage in vivo
(cited in reference 22). In vitro, the K181 strain of MCMV was
reported to show smaller plaques than the Smith strain of
MCMV and to grow to lower titers (15). In vivo, the K181
strain of MCMV was originally reported to replicate to higher
titers in the salivary glands of infected mice (22) and to dem-
onstrate enhanced mortality in young mice (cited in reference
15). The passage histories of the Smith and K181 strains of
MCMV are uncertain, and the mouse strain from which they
were derived has not been recorded.
If the use of clinical isolates of HCMV is required to fully
understand the complex biology of this virus, it is axiomatic
that the use of serially passaged isolates of MCMV as a model
of clinical HCMV infection needs to be reassessed. Between
the first isolation of the Smith strain of MCMV and 2007, there
have been almost 3,000 studies published on various aspects of
MCMV biology. However, fewer than 1% of these (including
references 4, 9, 11, 12, 14, 20, and 32) use a virus strain other
than Smith or K181. In order to extend the MCMV model to
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other low-passage isolates of MCMV, we sequenced the viral
genomes and mapped the in vivo growth capacity of three
low-passage strains of MCMV in susceptible (BALB/c) and
resistant (C57BL/6 and CBA) mice. These MCMV strains
were isolated from wild caught mice and have defined origins
and passage histories. These three isolates were compared to
K181 bacterial artificial chromosome (BAC) vARK25 (27),
which was also sequenced in the present study. We determined
that the host resistance patterns described for “MCMV” are
not constant for all strains of the virus.
Sequencing of the entire genome of three “clinical” strains
of MCMV, plus the K181 laboratory strain, identified several
regions with extensive sequence variation (compared to the
Smith strain), which are presumably responsible for these dif-
ferent traits. This comparative approach has also resulted in a
reannotation of the published Smith strain genome sequence.
The maintenance of these fully sequenced low-passage strains
of MCMV will prove invaluable in teasing out the intricacies of
this animal model of an important human pathogen.
MATERIALS AND METHODS
Viruses and cells. The BAC clone of K181, pARK25, has been described
previously (27). The virus strains G4, WP15B, and C4A have also been described
previously (14, 32). The BAC clone of the Smith strain of MCMV, pSM3fr, has
been described previously (36) and was kindly provided by Ulrich Koszinowski
(Max von Pettenkofer Institute, Munich, Germany). Viruses were inoculated
onto murine embryonic fibroblasts (MEFs) from BALB/c mice from stocks as
close to the original plaque-purified virus as was possible. Viruses used for
sequencing were packaged in vitro a maximum of five times after plaque puri-
fication (to minimize tissue culture-derived artifacts) and are therefore described
as low-passage strains of MCMV. Multistep viral growth curves were performed
as previously described (18) on BALB/c MEFs. Salivary gland stocks of each
virus were derived by passage in BALB/c, C57BL/6, or CBA weanling mice, as
appropriate.
Viral characterization. A total of 104 PFU of salivary gland virus stocks was
inoculated intraperitoneally into BALB/c, C57BL/6, or CBA mice as appropri-
ate. Mice were sacrificed at days 3 and 18 postinoculation (n  5 per time point),
and tissues were collected for analysis. Infectious virus from organs was quanti-
fied by plaque assay on MEFs. Statistical analyses were performed by using the
Kruskal-Wallis one-way analysis of variance on ranks.
DNA purification. DNA was extracted from virus-infected cells as previously
described (27) Briefly, four T80 flasks of M2-10B4 cells were infected with virus,
and when the cytopathic effect reached 100% the cells were harvested by freezing
and scraping. Virus was pelleted from the supernatant at 29,000  g for 30 min
at 4°C, and the pellet was resuspended in 500 l of DNase I buffer. Extraviral
DNA was digested for 1 h in 0.2 U of DNase I. Virus was treated with 500 l of
1% sodium dodecyl sulfate and 40 l of proteinase K (20 mg/ml) for a minimum
of 4 h at 56°C. Viral DNA was purified by two phenol-chloroform extractions and
precipitated in 1 volume of isopropanol. pARK25 BAC DNA was extracted from
Escherichia coli strain DH10B by using the Nucleobond plasmid kit (Clontech,
Palo Alto, CA).
Sequencing and sequence assembly. Viral genomes were initially sequenced by
a 454 Life Sciences sequencer (Branford, CT). Contigs were joined, and se-
quences were closed by PCR and dye-terminator sequencing. Anomalous se-
quences were confirmed by PCR and dye-terminator sequencing.
Sequence analysis. Sequences were assembled and analyzed by using Vector
NTi sequence software (Invitrogen). Amino acid similarities were calculated by
using MatGat (7) Dot plot comparisons were performed by using Dottup on the
Emboss server at the Centre for Comparative Genomics at Murdoch University.
The moving window analysis of genomic sequences was performed by using a
MLAGAN alignment (5) analyzed using the VISTA server (13) running at
genome.lbl.gov.
Accession numbers. Virus genome sequences are deposited in the EMBL
database under accession numbers AM886412 and EU579859 to EU579861.
RESULTS AND DISCUSSION
The genome of the Smith strain of MCMV was first pub-
lished in 1996 (26), and since this time only small sequences
(full or partial genes) from other strains of MCMV have been
published. These studies have shown that certain MCMV
genes exist as distinct genotypes within the population of wild
MCMV strains (9, 32). We have a large collection of MCMV
strains that have been isolated from wild mice trapped in
different locations within Australia, as well as several island
locations. The virus strains described here include G4, isolated
from a mouse trapped in Geraldton, Western Australia (dis-
tance from Canberra, 3,300 km); WP15B, isolated from a
mouse trapped in Walpeup, Victoria (distance from Canberra,
650 km); and C4A, isolated from a mouse trapped in Can-
berra. We therefore consider these viruses to be geographically
distinct isolates. In addition, we have recently constructed a
BAC clone of the laboratory strain of MCMV, K181Perth. This
clone, designated vARK25, was shown to be identical to the
parental virus by restriction fragment length polymorphism
analysis and both in vivo and in vitro growth characteristics
(27) and is designated K181 here.
Comparison of the four new viral genome sequences to the
published Smith strain sequence identified several genes where
the four new sequences were identical, but the Smith sequence
contained a 1- or 2-nucleotide (nt) indel which changed an
open reading frame (ORF). Subsequent analysis of the litera-
ture showed that several of these changes had been reported
on an ad hoc basis (6, 16). Accordingly, we resequenced these
regions from the BAC clone of the Smith virus, pSM3fr, and
found that all of these regions had been incorrectly sequenced
within the original publication (Table 1). The Smith genome
has thus been reannotated accordingly (NC_004065), and all of
our comparisons were performed against this genome. Two
genes (m30 and m45.1) have been removed from the annota-
tion, since they are now part of surrounding coding sequences.
The M59 gene was found to contain multiple frameshift errors
in all five viruses, and we have therefore also removed this gene
from the annotation. However, we left the gene m107 within
the annotation, despite this ORF only being present in the
TABLE 1. Genes identified in the Smith strain of virus that have
been reannotated in this analysis
Smith gene changeda Change(s)
M20 ...................C removed at 20958, extends ORF 3
M26 ...................G inserted at 31975, extends ORF 5
m29....................G inserted at 36197, extends ORF
m29.1.................G inserted at 36197, truncates ORF
m31....................C insertion at 37262, creates readthrough from
m30 into m31
m45....................C insertion at 61919, creates readthrough into
m45.1
m58....................A removed at 92089, G inserted at 92178, G
inserted at 92179, G removed at 92358,
changes the central region of the ORF
m143*................No changes, but extends to 5ATG
m150..................C inserted at 208711, results in use of internal
ATG
m163*................No changes, but extends to 5ATG
a *, An internal start codon may still be used. Genes m30, m45.1, and m59 were
deleted.
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FIG. 1. Genomic analysis of MCMV strains. (A) Dot plot comparisons of newly sequenced virus strains shows no major insertions, deletions,
or genomic rearrangements (*) as are seen in similar strain comparisons of HCMV (AD169 versus Merlin) and RhCMV (180.92 versus 68-1).
(B) Vista plot of aligned genome sequences shows that sequence variation is predominantly toward the genomic termini.
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Smith virus and there being no evidence of transcription from
this region (34). In the reannotated genome, we also included
the 11 new genes that have been identified subsequent to the
original publication and for which there are experimental data
(16, 19, 34). It appears evident due to the different genotypes
seen for m05, m06, m15, and m154.3 that, while K181 is closely
related to the Smith strain of MCMV, it is not simply a variant
of it.
One of the reasons MCMV is widely used in animal models
of HCMV infection is because the genomes of MCMV and
HCMV are colinear. Analysis of the genomic sequences of
laboratory and clinical strains of HCMV has demonstrated



























































































































































































K181 G4 C4A WP15B K181 G4 C4A WP15B
FIG. 2. Summary of coding potential of newly sequenced strains. Genes are color coded according to their amino acid similarity to the
reannotated Smith strain sequence (reannotated genes highlighted in pink). Spliced genes indicated by arrows. Variation is mostly found in the
putative “immune evasion” genes. Sections denoted by “`” indicate that no ORF present.
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that viral genome size is variable, with a difference of 13,598 bp
between the Towne (laboratory strain) and Merlin (clinical
strain) strains that results in the loss of a number of ORFs in
the laboratory strains (25). Similar variation has been found in
the genome sizes of the rhesus CMV strains 180.92 (215,678
bp) and 68-1 (221,454 bp). Consequently, similar differences
were expected between the genome size of Smith and K181
compared to the low-passage MCMV strains. The genome size
of the (reannotated) Smith strain of MCMV is 230,281 bp and
that of the newly sequenced K181 is 230,251 bp. In contrast to
expectations, the genome sizes of the low-passage strains was
highly conserved (WP15B, 230,118 bp; C4A, 230,105 bp; G4,
230,229 bp), with a maximum size variation of only 0.087%.
Dot plot comparisons of the Smith strain genome against each
of the newly sequenced genomes demonstrate that, in addition
to the conserved genome size, genome organization is also
conserved with no obvious rearrangements or large indels of
the type seen in the HCMV and RhCMV genomes (Fig. 1A).
Hence, the genome of the Smith strain of MCMV appears to
be highly conserved over 50 years of passage. This could be due
to repeated in vivo passage since isolation (interestingly, the
Vancouver strain of MCMV was shown to be a variant of
Smith which had undergone significant genomic rearrange-
ment during serial in vitro passage and was significantly atten-
uated for in vivo growth ([3]) or to the lack of the repeat
sequences that are present in the human and rhesus CMV
genomes. The conservation of genome size also suggests that
230 kb is close to the maximal size capable of being packaged
within the MCMV virion, possibly due to constraints imposed
by the size of the viral capsid.
Sequence variation. A rolling-window comparison of the
genomic sequences of the low-passage strains against the Smith
sequence (Fig. 1B) demonstrates that, as expected, the most vari-
able regions of the genome are at the left (m01 to m19) and right
(m144 to m170) termini. However, individual genes elsewhere in
the genome may also be highly variable (for example, M55 and
m124). Within the rest of the genome there is remarkable con-
servation of sequence such that, of the 190 coding regions within
the MCMV genome, more than 78% (151 ORFs) have 98%
amino acid similarity to the coding potential of the Smith strain of
virus (Fig. 2). Interesting features include the fact that both C4A
and WP15B encode the variant m03.5 rather than m03 (9) and
the 7.2-kb intron (17) encoded between m106 and m108 is highly
conserved, although the low-passage strains contain a 3-nt inser-
tion within the suggested splice acceptor site.
The variability between MCMV strains is not simply limited
to changes in amino acid sequence. Based on the assumption
that a coding sequence would extend at least 60 amino acids
from a start codon, several previously identified genes are not
present in at least one of the newly sequenced strains (Table
2). One of these genes, m154.4, was shown to be transcribed in
the Smith strain with early kinetics, and its product localized
in the nucleus of infected cells (34); however, it is not present
in any of the low-passage strains. Indeed, it seems possible that
even where transcripts have been identified from certain
ORFs, for example, m01, there may not actually be functional
genes present.
A major type of variation between strains appears to be
changes to the lengths of ORFs (Table 2). Of interest is the
sequence of m123 exon 4, which in the low-passage strains
extends to a start codon 86 amino acids upstream of the iden-
tified splice acceptor site (21). Although changes to the puta-
tive start codon of a gene may not be valid (as an internal ATG
may still be used), a large number of genes are either 3
truncated due to an internal stop codon or 3 extended due to
indels changing the reading frame of the gene. One such gene
is the M33 from G4, which contains a single nucleotide poly-
morphism creating a stop codon that truncates the protein by
35 amino acids. The truncated region includes five serines and
one threonine residue that are suggested to be possible phos-
phorylation sites involved in protein signaling (30). Further
research is needed to determine the level of functional varia-
tion resulting from these changes. In addition, detailed com-
parative genomic analysis will undoubtedly reveal new ORFs
awaiting characterization.
The in vivo and in vitro replication kinetics of these viruses
was assessed to determine whether genetic differences resulted
in altered phenotypes. The growth of MCMV strains in vitro is
a function of the ability of the virus to enter, replicate, and exit
from a cell. As far as is known for MCMV, the genes that
encode these functions are located within the central region of
TABLE 2. Comparative analysis of the MCMV genome
Category Geneb Virus strain(s) affected
ORFs present in lab
strains but not low-
passage isolates
m01 All low-passage isolates
m12 G4
m19 G4
m21* All low-passage isolates
m107* Only present in Smith
m145.4 All low-passage isolates
m154.4 C4A, WP15Bc
m156 G4, WP15B
Changes relative to Smith
Upstream start codon
(extends ORF)a











m69.1 All low-passage isolates











m119 All low-passage isolates




a An internal start codon may still be used.
b *, No transcript was detected by Tang et al. (34).
c The presence of an internal stop codon means the ORF is only 25 amino
acids in length.
d The start codon is 86 amino acids upstream of the identified splice site.
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the genome and are highly conserved between strains. These
viruses should therefore have similar in vitro replication kinet-
ics. This was indeed the case for replication in MEFs (Fig. 3A).
Given that none of these virus strains have inherent growth
defects in MEFs, it must be assumed that any differences in
their growth in vivo is due to either differences in tissue tro-
pism or immune evasion. To assess this issue, three strains of
mice with known resistance to MCMV—BALB/c (susceptible),
C57BL/6 (moderately resistant), and CBA (resistant)—were
infected with each viral strain (1). Viral titers were assessed in
the spleens and livers at day 3 and in the salivary glands at day
18. Using multiple strains of MCMV in inbred mouse strains,
the previous assertions about host resistance to MCMV are
less obvious, since there was considerable variation in the abil-
ity of MCMV strains to replicate (Fig. 3B). Generally, there
was some support for the previously identified mouse resis-
tance to infection, with BALB/c mice typically having higher
MCMV titers in the spleens, livers, and salivary glands (of
infected mice) than did CBA or C57BL/6 mice. However, CBA
mice appeared to be no more resistant to MCMV than
C57BL/6 mice and in fact appeared to be slightly more sensi-
tive to MCMV infection as reflected by the virus titers in the
liver.
When these resistance patterns were assessed for individual
virus strains, the pattern of mouse resistance is further com-
plicated. For example, WP15B replicates to higher titers in the
spleens and salivary glands of C57BL/6 mice than the titers
found in BALB/c and CBA mice. Typically, Smith and K181
replicate preferentially in the spleens compared to the livers of
infected mice, and it was control of viral replication in the
spleens of C57BL/6 mice that led to the discovery of the Cmv1
locus and the interaction of host Ly49H and virus-encoded
m157 (28). This pattern of replication was confirmed in all
three strains of mice for K181 and for the low-passage isolates
of MCMV in BALB/c mice. However, the low-passage isolates
of MCMV consistently replicated to higher titers in the livers
compared to the spleens of infected CBA mice. These data
suggest a different host control mechanism in the spleens or
FIG. 3. Phenotypic characterization of MCMV strains. (A) In vitro growth curves in MEFs. There is no inherent growth defect in any of the
MCMV strains in MEFs. (B) In vivo growth of MCMV strains in inbred mice with defined resistances to Smith strain MCMV. Significant
differences (bracketed) can be seen in viral tires according to tissue, mouse strain, and virus strain. (C) Resistance patterns of inbred mouse strains
to MCMV. Relative resistances of inbred mouse strains differ according to the virus strain used and do not simply reiterate the known patterns
for the Smith strain of virus.
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livers of infected CBA mice for the wild viral strains than for
the laboratory strains of MCMV. Hence, resistance to MCMV
is complicated and is dependent on the mouse strain, tissue
type, and MCMV strain (Fig. 3C). It would therefore perhaps
be more appropriate to designate resistance relative to virus
strain rather than to mouse strain.
When a particular resistance mechanism is known, then the
genome of the virus can be used to predict in vivo replication
in specific tissues in specific mouse strains. The m157 gene
product of the Smith and K181 strains can directly ligate the
NK cell-activating receptor, Ly49H (2). Consequently, replica-
tion of K181 and Smith strain MCMV is well controlled in the
spleens of C57BL/6 mice or other Ly49H mice. The m157
gene from C4A is of the same genotype as that of K181 (92.8%
amino acid similarity), and we hypothesize should ligate
Ly49H. This virus should therefore replicate poorly in the
spleens compared to the livers of C57BL/6 mice, and this is
indeed the case. In contrast, WP15B and G4 have other geno-
types (76.9 and 77.8% amino acid similarity, respectively). The
m157 gene product from G4 has been shown not to interact
with Ly49H from C57BL/6 (35), and presumably neither does
that of WP15B. Both WP15B and G4 replicate better in the
spleens than in the livers of C57BL/6 mice as predicted. Hence,
the genetics of a viral strain can have a profound effect on host
resistance to MCMV and, in the case of m157 (in Ly49H
mice), can be used to predict in vivo replication. Subsequently,
direct ligation of Ly49H by C4A-infected MEFs was demon-
strated with BWZ-HD12 cells (31), kindly provided by A. A.
Scalzo (data not shown).
Given that the previously described host resistance patterns
to MCMV infection are not reproduced for all strains of
MCMV, it may be possible to apply a comparative approach by
which previously unidentified host resistance mechanisms may
be determined. This may also allow for the comparison of not
only mouse strain resistance to virus but also virus resistance to
mouse strain control of infection. This could allow for a new
“comparative resistomics” approach to MCMV biology.
In conclusion, we have demonstrated significant sequence
variation between strains of MCMV and differences in the in
vivo replication of these strains of virus. We have purposefully
sequenced only low-passage “wild” strains of MCMV and will
maintain these as reference strains. In addition, the cloning
and sequencing of the K181Perth BAC will facilitate the use of
this strain of virus as a reference strain. We are currently
cloning the genome of each of the sequenced viruses as BAC
clones to allow the maintenance of a clonal reference genome
for each virus.
Within the MCMV genome we do not find major changes
due to deletions or insertions of genes, as is seen in HCMV
in RhCMV. Indeed, this appears unlikely to occur in
MCMV strains, given the remarkable conservation of ge-
nome size that we have observed. Differences in virus rep-
lication are likely to be due to variation in gene sequences
rather than wholesale changes to gene content. These more
subtle changes result in considerable changes to in vivo
replication capacity. Consequently, it is not possible extrap-
olate results from one MCMV strain to “MCMV biology” as
a whole.
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